Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword

INTRODUCTION: The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic problem. The lung is the major target organ of SARS‐CoV‐2 and some of its variants like Delta and Omicron variant adapted i...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Geetika, Dhawan, Manish, Saied, AbdulRahman A., Kaur, Geetika, Kumar, Reetesh, Emran, Talha Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521379/
https://www.ncbi.nlm.nih.gov/pubmed/37773723
http://dx.doi.org/10.1002/iid3.1020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521379/
https://www.ncbi.nlm.nih.gov/pubmed/37773723
http://dx.doi.org/10.1002/iid3.1020

Ejemplares similares